These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33968641)

  • 21. Reevaluation of genetic variants previously associated with arrhythmogenic right ventricular cardiomyopathy integrating population-based cohorts and proteomics data.
    Ye JZ; Delmar M; Lundby A; Olesen MS
    Clin Genet; 2019 Dec; 96(6):506-514. PubMed ID: 31402444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with coronary heart disease, dilated cardiomyopathy and idiopathic ventricular tachycardia share overlapping patterns of pathogenic variation in cardiac risk genes.
    Guelly C; Abilova Z; Nuralinov O; Panzitt K; Akhmetova A; Rakhimova S; Kozhamkulov U; Kairov U; Molkenov A; Seisenova A; Trajanoski S; Abildinova Rashbayeva G; Kaussova G; Windpassinger C; Lee JH; Zhumadilov Z; Bekbossynova M; Akilzhanova A
    PeerJ; 2021; 9():e10711. PubMed ID: 33552729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants.
    Pottinger TD; Puckelwartz MJ; Pesce LL; Robinson A; Kearns S; Pacheco JA; Rasmussen-Torvik LJ; Smith ME; Chisholm R; McNally EM
    J Am Heart Assoc; 2020 Feb; 9(3):e013808. PubMed ID: 32009526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.
    Chetruengchai W; Shotelersuk V
    J Hum Genet; 2022 Mar; 67(3):137-142. PubMed ID: 34621001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells.
    Lombardi R; Marian AJ
    Curr Opin Cardiol; 2010 May; 25(3):222-8. PubMed ID: 20124997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G790del mutation in DSC2 alone is insufficient to develop the pathogenesis of ARVC in a mouse model.
    Hamada Y; Yamamoto T; Nakamura Y; Sufu-Shimizu Y; Nanno T; Fukuda M; Ono M; Oda T; Okuda S; Ueyama T; Kobayashi S; Yano M
    Biochem Biophys Rep; 2020 Mar; 21():100711. PubMed ID: 31872082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
    Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of established arrhythmogenic right ventricular cardiomyopathy mutation in a patient with the contrasting phenotype of hypertrophic cardiomyopathy.
    Bainbridge MN; Li L; Tan Y; Cheong BY; Marian AJ
    BMC Med Genet; 2017 Mar; 18(1):24. PubMed ID: 28253841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort.
    Johnston JJ; Brennan ML; Radenbaugh B; Yoo SJ; Hernandez SM; ; Lewis KL; Katz AE; Manolio TA; Biesecker LG
    Genet Med; 2022 Mar; 24(3):736-743. PubMed ID: 34906458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience.
    Scheel PJ; Giuliano K; Tichnell C; James C; Murray B; Tandri H; Carter D; Fehr T; Umapathi P; Vaishnav J; Lewsey SC; Hsu S; Calkins H; Sharma K; Choi CW; Gilotra NA; Kilic A
    ESC Heart Fail; 2022 Apr; 9(2):1008-1017. PubMed ID: 34953065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of low coverage in whole-exome genetic testing in the assessment of familial arrhythmogenic right ventricular cardiomyopathy: a case report.
    Costa S; Pons E; Medeiros-Domingo A; Saguner AM
    Eur Heart J Case Rep; 2021 Jun; 5(6):ytab111. PubMed ID: 35721821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.
    Carruth ED; Beer D; Alsaid A; Schwartz MLB; McMinn M; Kelly MA; Buchanan AH; Nevius CD; Calkins H; James CA; Murray B; Tichnell C; Matsumura ME; Kirchner HL; Fornwalt BK; Sturm AC; Haggerty CM
    Circ Genom Precis Med; 2021 Apr; 14(2):e003302. PubMed ID: 33684294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy.
    Klauke B; Kossmann S; Gaertner A; Brand K; Stork I; Brodehl A; Dieding M; Walhorn V; Anselmetti D; Gerdes D; Bohms B; Schulz U; Zu Knyphausen E; Vorgerd M; Gummert J; Milting H
    Hum Mol Genet; 2010 Dec; 19(23):4595-607. PubMed ID: 20829228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequenom MassARRAY approach in the arrhythmogenic right ventricular cardiomyopathy post-mortem setting: clinical and forensic implications.
    Alcalde M; Campuzano O; Allegue C; Torres M; Arbelo E; Partemi S; Iglesias A; Brugada J; Oliva A; Carracedo A; Brugada R
    Int J Legal Med; 2015 Jan; 129(1):1-10. PubMed ID: 24832006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrhythmogenic Right Ventricular Cardiomyopathy - 4 Swedish families with an associated PKP2 c.2146-1G>C variant.
    Svensson A; Åström-Aneq M; Widlund KF; Fluur C; Green A; Rehnberg M; Gunnarsson C
    Am J Cardiovasc Dis; 2016; 6(2):55-65. PubMed ID: 27335691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation.
    Lin Y; Huang J; He S; Feng R; Zhong Z; Liu Y; Ye W; Li X; Liao H; Fei H; Rao F; Shan Z; Deng C; Zhan X; Xue Y; Liu H; Zhang B; Wang K; Zhang Q; Wu S; Lin X
    BMC Med Genet; 2018 Aug; 19(1):148. PubMed ID: 30129429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular Characteristics of Patients with Genetic Variation in Desmoplakin (
    Reza N; de Feria A; Chowns JL; Hoffman-Andrews L; Vann L; Kim J; Marzolf A; Owens AT
    Cardiogenetics; 2022 Mar; 12(1):24-36. PubMed ID: 35083019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders?
    Christensen AH; Benn M; Tybjaerg-Hansen A; Haunso S; Svendsen JH
    Cardiology; 2010; 115(2):148-54. PubMed ID: 19955750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.
    Pilichou K; Nava A; Basso C; Beffagna G; Bauce B; Lorenzon A; Frigo G; Vettori A; Valente M; Towbin J; Thiene G; Danieli GA; Rampazzo A
    Circulation; 2006 Mar; 113(9):1171-9. PubMed ID: 16505173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes.
    Gréen A; Gréen H; Rehnberg M; Svensson A; Gunnarsson C; Jonasson J
    J Mol Diagn; 2015 Jan; 17(1):31-42. PubMed ID: 25445213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.